The prospect for vaccines to prevent Clostridium difficile infection.
about
An update on antibody-based immunotherapies for Clostridium difficile infectionDissemination of Clostridium difficile in food and the environment: Significant sources of C. difficile community-acquired infection?Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliCNovel approaches to treating Clostridium difficile-associated colitis.Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.Breakthroughs in the treatment and prevention of Clostridium difficile infection.Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray Analysis.Immunogenicity and protective efficacy of Clostridium difficile spore proteins.Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease PatientsBezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection.Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.Rethinking the role of alpha toxin in Clostridium perfringens-associated enteric diseases: a review on bovine necro-haemorrhagic enteritis.Vaccines for Healthcare-associated Infections: Promise and Challenge.First recurrence of Clostridium difficile infection: clinical relevance, risk factors, and prognosis.Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting.
P2860
Q26740788-D9E0C4D9-9213-4970-A852-4C2C246FC6D8Q30241810-044D0DB8-9699-4983-9786-ACCCC0D769F4Q34512085-BFDF87C7-B43E-4490-B910-0980F52143B1Q35862915-4F800DBC-37B9-4B1C-AD76-A657E98E8E59Q35918139-0EA7487C-9C7F-42C6-970E-5E7CAF165315Q35918566-1ABC150F-A13F-4284-9572-2BE4DDB57569Q35998772-7272308F-B5E9-4A3A-9523-0767243BB77DQ36630071-C2F19415-5C79-40A4-82C2-F508E7405517Q36689391-47B361BC-8DB7-4CA8-8F94-6E251E233882Q38668483-FD5098E3-FFB5-4782-A7D5-1028968A1092Q38717600-CD7E9205-B4B0-40FF-9220-1816A6BA92E7Q39139458-15A14E4E-077B-4EC6-B825-6CFCD695C99EQ40665389-D1B6AE78-18AF-493E-8014-F1ED5650E58AQ40837374-4EE60976-5095-4541-9843-1EA2540321A5Q47164620-0701E2DD-0A75-426D-992F-4F19A858369FQ54239070-8ACE8165-2932-4D28-94A7-7E340725B4F4
P2860
The prospect for vaccines to prevent Clostridium difficile infection.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The prospect for vaccines to prevent Clostridium difficile infection.
@ast
The prospect for vaccines to prevent Clostridium difficile infection.
@en
The prospect for vaccines to prevent Clostridium difficile infection.
@nl
type
label
The prospect for vaccines to prevent Clostridium difficile infection.
@ast
The prospect for vaccines to prevent Clostridium difficile infection.
@en
The prospect for vaccines to prevent Clostridium difficile infection.
@nl
prefLabel
The prospect for vaccines to prevent Clostridium difficile infection.
@ast
The prospect for vaccines to prevent Clostridium difficile infection.
@en
The prospect for vaccines to prevent Clostridium difficile infection.
@nl
P1476
The prospect for vaccines to prevent Clostridium difficile infection.
@en
P2093
Chandrabali Ghose
Ciarán P Kelly
P304
P356
10.1016/J.IDC.2014.11.013
P577
2015-03-01T00:00:00Z